低血糖与糖尿病心血管疾病及死亡:流行病学、机制与管理
本文综述低血糖作为胰岛素或促泌剂治疗糖尿病的危险副作用,可影响脑功能并干扰生活。实验与临床研究提示低血糖与心血管事件及死亡风险增加相关,机制可能涉及心律失常等,但关联部分由合并症混杂导致。临床设定血糖目标与选择降糖药时应识别该风险。
要点
- 低血糖是胰岛素或促泌剂治疗糖尿病的危险副作用,可影响脑功能。
- 研究提示低血糖与心血管事件及死亡风险增加相关,机制可能为多因素。
- 合并症混杂部分解释关联,但1型或2型糖尿病患者仍存低血糖心血管风险。
核心结论
- 低血糖与心血管事件及死亡风险增加相关,关联可能为多因素且部分由合并症混杂所致。
- 1型或2型糖尿病患者仍存在低血糖诱导的心血管效应风险。
研究设计与样本
- 本文为综述,汇总实验研究与临床研究关于低血糖与心血管事件及死亡的证据。
主要发现
- 实验研究识别了低血糖可能诱发心血管事件的不同机制。
- 临床研究报告低血糖可诱导心律失常,其中一份报告描述严重低血糖发作期间发生猝死。
- 低血糖在合并症更多的人群中更频繁发生,而这些人群死亡风险也更高,提示混杂部分解释关联。
临床怎么用
- 临床医生在与患者商定血糖目标及选择合适降糖治疗时,应识别低血糖的心血管风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypoglycaemia has long been recognised as a dangerous side-effect of treatment of diabetes with insulin or insulin secretagogues. With its potential to disrupt cerebral function, hypoglycaemia can have a major effect on peoples' lives. Study findings have suggested that hypoglycaemia is associated with an increased risk of cardiovascular events and mortality. Different mechanisms by which hypoglycaemia might provoke cardiovascular events have been identified in experimental studies, and in clinical studies cardiac arrhythmias have been reported to be induced by hypoglycaemia, with one report describing sudden death during a severe episode. Emerging evidence suggests that the association between hypoglycaemia and cardiovascular events and mortality is likely to be multifactorial. The association is probably partly caused by confounding, with hypoglycaemia occurring more frequently in people with comorbidities who are also more likely to die than those without. However, people with type 1 or type 2 diabetes also seem at risk of hypoglycaemia-induced cardiovascular effects. This risk should be recognised by clinicians when agreeing glycaemic goals with patients and choosing appropriate glucose-lowering therapies.
引用
- Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019. PMID: 30926258. doi:10.1016/S2213-8587(18)30315-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。